arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Jade Biosciences, Inc.

JBIO

$16.75 ▼ -0.02 (-0.09%) at close

27 Visible periods

19 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Jade Biosciences, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.0B

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -13.4% ↗

FCF / Share $-0.72 ↘

Trailing P/E —

Price / Book 2.4x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 22, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-40.37M

↓ -5.8% —

FCF / Share Free cash flow per share

$-0.72

↓ -71.6% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	11.6% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-533.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	42.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	14.3% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	89.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	74.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	21.1% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-13.2% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-23.9% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-21.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-26.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-55.1% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-48.9% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-771.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-115.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	97.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	96.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-5.8% Weak ↑ Weak Improving Year-over-year change in net income	-1503.2% Weak ↓ Weak Declining Year-over-year change in net income	-488.1% Weak ↓ Weak Declining Year-over-year change in net income	-64.6% Weak ↓ Weak Declining Year-over-year change in net income	-64.6% Weak ↓ Weak Declining Year-over-year change in net income	89.1% Excellent ↑ Excellent Improving Year-over-year change in net income	73.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-40.4% Weak → Weak Stable Year-over-year change in net income	-40.4% Weak ↑ Weak Improving Year-over-year change in net income	-40.4% Weak ↑ Weak Improving Year-over-year change in net income	-35.9% Weak ↑ Weak Improving Year-over-year change in net income	-51.4% Weak ↑ Weak Improving Year-over-year change in net income	-51.4% Weak ↑ Weak Improving Year-over-year change in net income	-51.4% Weak ↑ Weak Improving Year-over-year change in net income	-82.7% Weak ↑ Weak Improving Year-over-year change in net income	-292.3% Weak ↓ Weak Declining Year-over-year change in net income	-292.3% Weak ↓ Weak Declining Year-over-year change in net income	-292.3% Weak ↓ Weak Declining Year-over-year change in net income	-124.3% Weak ↓ Weak Declining Year-over-year change in net income	-93.7% Weak Weak Year-over-year change in net income	-93.7% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	—	-407.4% Weak Weak Year-over-year change in free cash flow	—	-0.8% Weak Weak Year-over-year change in free cash flow	—	90.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-84.5% Weak Weak Year-over-year change in free cash flow	—	—	—	-98.1% Weak Weak Year-over-year change in free cash flow	—	—	—	98.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Effective Tax Rate (%) (%)	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.08x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.58x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.95x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	2.03x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.02x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.69x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.52x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.60x Excellent ↓ Excellent Declining Free cash flow relative to reported net income Optimal: > 1x	2.37x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.44x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.37x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.69x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-13.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-21.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	21.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	13.6% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	21.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	18.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	17.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-12.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-13.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-13.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-4.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-77.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-9.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-161%)	-13.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-191%)	-9.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-164%)	-21.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-242%)	-18.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-226%)	-3.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-122%)	-7.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-147%)	-28.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-292%)	-24.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-264%)	-25.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-270%)	-18.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-224%)	-13.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-188%)	-11.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-178%)	-14.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-197%)	-11.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-179%)	-7.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-152%)	-7.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-148%)	-6.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-145%)	-4.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-132%)	-1.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-110%)	12.9% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-14%)	17.3% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+15%)	27.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+83%)	14.8% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	19.8% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+32%)	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Net Debt (USD)	$-107.25M	$-55.09M	$-88.44M	$-50.11M	$-220.94M	$-44.22M	$-33.75M	$-31.11M	$-31.07M	$-9.12M	$-23.49M	$-32.18M	$-60.90M	$-26.57M	$-22.40M	$-22.42M	$-27.46M	$-28.14M	$-54.20M	—	—	—	$-4.57M	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Basic EPS, GAAP (USD)	$-0.76	$-0.57	$-0.11	$-0.48	$-0.86	$-0.09	$-0.19	$-0.56	$-0.86	$-0.83	$-0.74	$-0.71	$-0.76	$-0.67	$-0.61	$-0.56	$-0.49	$-0.45	$-0.07	$-0.26	$-23.80	$-11.49	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.72	$-0.42	—	$-0.56	—	$-0.08	—	$-0.56	$-0.71	$-0.85	—	—	—	$-0.46	—	—	—	$-0.23	—	$-0.28	$-16.48	$-15.69	—	—	—	—	—
Book Value per Share (USD)	$6.92	$6.01	$6.74	$5.50	$6.18	$2.59	$2.64	$2.79	$3.27	$3.26	$3.94	$4.55	$5.14	$4.56	$5.13	$5.68	$6.19	$6.63	$7.06	$7.53	$-88.77	$-66.30	$-54.90	—	—	—	—
Tangible Book Value per Share (USD)	$6.92	$6.01	$6.74	$5.50	$6.18	$2.59	$2.64	$2.79	$3.27	$3.26	$3.94	$4.55	$5.14	$4.56	$5.13	$5.68	$6.19	$6.63	$7.06	$7.53	$-88.77	$-66.30	$-54.90	—	—	—	—
Basic Weighted Avg Shares (shares)	61.05M	57.78M	—	39.58M	28.43M	28.99M	—	28.86M	28.76M	27.80M	—	27.64M	25.17M	24.78M	—	24.45M	24.41M	24.41M	—	23.89M	243,076	243,076	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$439.68M	$296.23M	$332.28M	$179.00M	$201.36M	$74.96M	$76.29M	$80.29M	$93.74M	$87.72M	$106.59M	$122.88M	$139.19M	$109.93M	$123.71M	$137.45M	$149.69M	$161.18M	$171.78M	—	—	—	$2.90M	—	—	—	—
Total Equity (USD)	$439.92M	$296.46M	$332.52M	$179.35M	$201.56M	$75.05M	$76.43M	$80.49M	$94.40M	$90.90M	$109.46M	$125.72M	$141.93M	$113.09M	$126.74M	$139.14M	$151.05M	$161.95M	$172.42M	$179.85M	$-21.58M	$-16.11M	$-13.34M	$-9.70M	$-7.27M	$-5.07M	$-3.64M

📋 What is driving earnings? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Depreciation Expense (USD)	$9.00K	$9.00K	$9.00K	$12.00K	—	$4.00K	$8.00K	$218.00K	$28.00K	$28.00K	$28.00K	—	—	$21.00K	$20.00K	—	—	$11.00K	$8.00K	$3.00K	$2.00K	$2.00K	—	—	—	—	—
Net Income, GAAP (USD)	$-40.37M	$-40.37M	$-31.93M	$-38.17M	$-38.17M	$-2.52M	$-5.43M	$-23.19M	$-23.19M	$-23.19M	$-20.41M	$-16.52M	$-16.52M	$-16.52M	$-15.02M	$-10.91M	$-10.91M	$-10.91M	$-8.22M	$-2.78M	$-2.78M	$-2.78M	$-3.67M	$-1.44M	$-1.44M	—	—
Operating Cash Flow (USD)	$-43.66M	$-24.08M	$-33.65M	$-22.12M	—	$-2.38M	$-11.05M	$-16.04M	$-20.43M	$-23.67M	$-14.80M	—	—	$-11.42M	$-14.87M	—	—	$-5.66M	$-13.09M	$-6.53M	$-4.00M	$-3.77M	$-2.88M	$-2.43M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 27 quarters

Jade Biosciences, Inc.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare JBIO with peers